EMA Authorised: Deqsiga (human normal immunoglobulin) — Takeda Manufacturing Austria AG

View source ↗

Summary

EMA authorised Deqsiga, a human normal immunoglobulin product from Takeda Manufacturing Austria AG, for several immunologic and neuropathic indications includin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Guillain-barré Syndrome
• Immune Thrombocytopenia
• Immunodeficiency
• Inflammatory Demyelinating Polyneuropathy
• Kawasaki Disease

Drugs mentioned

• Deqsiga (human normal immunoglobulin)

Snippet

Status: Authorised. Therapeutic area: Immunologic Deficiency Syndromes;Purpura, Thrombocytopenic, Idiopathic;Guillain-Barre Syndrome;Mucocutaneous Lymph Node Syndrome;Polyradiculoneuropathy, Chronic Inflammatory Demyelinating. MAH: Takeda Manufacturing Austria AG. Decision date: 02/05/2025